Denmark· DK-28106870222
LOQTORZI
A toripalimab product containing toripalimab, registered in Denmark by Topalliance Biosciences Europe Limited. The same ATC class is registered in 12 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Toripalimab is registered in 12 of 19 countries.
Countries holding a registration under ATC L01FF13 (toripalimab), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 8 of them publish a price we can compare per daily dose
Toripalimab · ATC L01FF13
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Toripalimab
- Manufacturer
- Topalliance Biosciences Europe Limited
- Country
- Denmark (DK)
- ATC code
- L01FF13
- ATC class
- Toripalimab
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28106870222
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under L01FF13
Toripalimab, as other registers publish it.
- PolandLoqtorziTMC Pharma (EU) Ltd.
- NorwayLoqtorziTopalliance Biosciences Europe Limited
- FinlandLOQTORZITopalliance Biosciences Europe Limited
- United StatesLOQTORZICoherus Oncology, Inc.
- IcelandLOQTORZITopalliance Biosciences Europe Limited.
- CzechiaLOQTORZITopalliance Biosciences Europe Limited, Dublin
- United StatesLOQTORZICoherus Oncology, Inc.
- BelgiumLoqtorzi 240 mgTopalliance Biosciences Europe
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f8dc79e1-728a-493d-bbf6-48470ba41956 GET /v1/drugs/f8dc79e1-728a-493d-bbf6-48470ba41956?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "koncentrat til infusionsvæske, opløsning",
"source": "dkma",
"strength": "240 mg",
"auth_role": "MOD",
"dk_drugid": "28106870222",
"substance": "Toripalimab",
"auth_procedure": "Central",
"in_medicinpriser": true,
"registration_date_serial": "45554"
}See everything about toripalimab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.